Katherine Siminovitch

Gilead Sciences (United States) — United States

Medicine · Health Sciences

40h-index12.4kcitations110works23.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Systemic Lupus Erythematosus Research(14), Genetic Associations and Epidemiology(13), Chronic Lymphocytic Leukemia Research(13), Galectins and Cancer Biology(11), Chronic Myeloid Leukemia Treatments(10)

Publications104 total

Genomic Ascertainment of <i>CHEK2</i> -Related Cancer Predisposition
JAMA Network Open·2025Open Access
Genes that cause severe liver disease in children also influence risk and severity of common liver conditions in adults
2025Open Access
Genetic risk factors for COVID-19 and influenza are largely distinct
Nature Genetics·2024· 10 citedOpen Access
Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk
JAMA Cardiology·2024· 41 citedOpen Access
A deep catalogue of protein-coding variation in 983,578 individuals
Nature·2024· 88 citedOpen Access
Author Correction: Genotyping, sequencing and analysis of 140,000 adults from Mexico City
Nature·2024· 1 citedOpen Access
SERPINH1 variants and thrombotic risk among middle-aged and older adults: a population-based cohort study
Journal of Thrombosis and Haemostasis·2023· 4 citedOpen Access
Genotyping, sequencing and analysis of 140,000 adults from Mexico City
Nature·2023· 84 citedOpen Access
P32 Statistical colocalization identifies twenty-four novel risk loci associated with disease risk of primary biliary cholangitis
Poster presentations·2023
Biallelic <i>BRCA</i> Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline <i>BRCA1/2</i> Carriers
JCO Precision Oncology·2023· 12 citedOpen Access
Rare coding variants in CHRNB2 reduce the likelihood of smoking
Nature Genetics·2023· 16 citedOpen Access
Supplementary Data from Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia
2023Open Access
Supplementary Data from Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia
2023Open Access
Data from Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia
2023Open Access
Data from Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia
2023Open Access
Inference of Causal Relationships Between Genetic Risk Factors for Cardiometabolic Phenotypes and Female‐Specific Health Conditions
Journal of the American Heart Association·2023· 15 citedOpen Access
Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis
Nature Genetics·2022· 328 citedOpen Access
Assessment of genetic susceptibility to multiple primary cancers through whole-exome sequencing in two large multi-ancestry studies
BMC Medicine·2022· 17 citedOpen Access
ANGPTL7, a therapeutic target for increased intraocular pressure and glaucoma
Communications Biology·2022· 22 citedOpen Access
Population-scale analysis of common and rare genetic variation associated with hearing loss in adults
Communications Biology·2022· 31 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Peter K. Gregersen(14), Eli A. Stahl(13), Robert M. Plenge(13), Soumya Raychaudhuri(12), Gang Xie(11), Jane Worthington(11), Leonid Padyukov(11), John D. Overton(11), Jeffrey G. Reid(11), Christopher I. Amos(10), Luca A. Lotta(10), Gonçalo R. Abecasis(9), Xiaodong Bai(9), Lukas Habegger(9), Evan K. Maxwell(9), Alan R. Shuldiner(9), Jeffrey Staples(9), Michael Cantor(9), Lars Klareskog(8), Fina Kurreeman(8)